Patent Application
20100273887
The present invention relates to products and mixtures comprising (a) pellitorin and (b) selected cooling agents. The present invention further relates to products and medicaments for soothing irritated oral and/or nasal tissues. The present invention also relates to the use of such mixtures for soothing irritated oral and/or nasal tissues and the use of such mixtures for reducing bitterness, in particular the bitterness of oral care products, confectionery products and medicaments, more specifically reducing the bitterness of menthol and menthol containing products and medicaments.
Many examples exist of medicaments designed to relieve or sooth irritated oral and nasal tissues. These medicaments typically rely upon a pharmaceutically active ingredient such as benzocaine which is a local anaesthetic. These ingredients, whilst on the whole successful, are sometimes not able to effectively sooth the nasal tissues and the nasopharyngeal region. Furthermore, the effects of pharmaceutically active ingredients such as these are sometimes considered by consumers as being more than is necessary to achieve the required results. A need exists for medicaments that provide a soothing effect in a moderate manner.
Soothing of irritated oral and nasal tissues may occur via increased moisturization of the tissues. However, many ingredients suitable for increasing moisturization of the oral and nasal tissues have noted drawbacks. For example, citric acid is able to increase oral salivation around the area of the tongue; yet is not able to improve moisturization in the entirety of the oral cavity and does not modulate nasal moisturization. This tends to prevent citric acid from being able to provide notable soothing effect in the nasophayngeal area. Furthermore, levels of citric acid that are capable of producing noticeable benefits around the tongue may taste acidic or astringent, and may also negatively impact product stability due to the high hygroscopicity of citric acid.
Further, a need exists to provide medicaments that successfully sooth irritated oral and/or nasal tissues without associated aesthetic negatives and/or product stability issues, preferably in addition being able to reduce the bitterness of oral care products, confectionery products and medicaments, in particular the bitterness of menthol.
U.S. Pat. No. 5,372,824 teaches a mint flavoured chewing gum having reduced bitterness comprising a mint flavour agent from which at least a portion of I-menthol has been removed. In an embodiment, the mint flavoured chewing gum includes a cooling agent, for example menthyl lactate. The cooling agent can comprise, for example 0.1% to 5.0% by weight of the reduced mint oil. Details of a peppermint fraction after menthol reduction, which is free of menthyl lactate, are also disclosed. Pellitorin is not mentioned.
US 2004/0018954 discloses mixtures containing menthol and menthyl lactate, characterized in that it comprises menthol and menthyl lactate in a ratio by weight in the range of 1:4 to 4:1 and the corresponding crystallization point is below room temperature of 25° C. Such a composition which is liquid at room temperature was produced by stirring menthol and menthyl lactate in solid form within the mentioned ratio without heating, i.e. without melting the components. Pellitorin is not mentioned.
WO 2004/000787 describes a method for producing 2E,4Z-decadienoic acid-N-isobutylamide (cis-pellitorin) and the use thereof as a pungent agent and a flavouring that generates heat, preferably in foodstuffs, oral hygiene or gourmet preparations. Menthol is not mentioned, nor specific cooling agents.
US 2004/0241312 concerns the use of 2E,4E-decadienoic acid-N-isobutylamide (trans-pellitorin) as flavourant, in particular as salivation inducing flavour substance, preferably in a foodstuff or nutrient, an oral hygienic preparation or a gourmet or snack preparation. Further, US 2004/0241312 concerns preparations, semi-finished preparations as well as fragrance, aroma and taste compositions, containing trans-pelletorin as well as a processes for the production of trans-pelletorin. Menthol is not mentioned, nor specific cooling agents.
US 2005/0075368 describes mixtures of at least four conjugated C10-C11-2E,4E-alkadienamides, obtainable synthetically or from a dried, ground Piper species, Piper longum Linn or Piper peepuloides, having flavour and sensory attributes in the oral cavity and on skin. Flavours like peppermint oil are mentioned, menthol is not mentioned, nor are specific cooling agents.
WO 2006/039945 relates to composition comprising menthyl lactate, neo-menthol and menthol, optionally further comprising neoisomenthol and/or isomenthol, wherein said composition has a solidification point below +5° C. Pellitorin is not mentioned.
US 2006/0204551 provides a salivation cocktail that comprises a food acid and a tingling sensate, the combination of a food acid and a tingling sensate synergistically increasing salivation, one of the tingling sensates mentioned is 2E,4E-decadienoic acid-N-isobutylamide (trans-pellitorin). In one embodiment of US 2006/0204551, a cough drop or lozenge is described containing a) menthol or other medicaments for the treatment of sore throat, coughing or other upper respiratory ailments and b) one of the salivation cocktails as described in US 2006/0204551. Peppermint oil is not mentioned, nor are cooling agents.
US 2007/0036838 teaches the use of certain salivating agents in the preparation of a medicament for soothing irritated oral and/or nasal tissues is provided. US 2007/0036838 further relates to compositions comprising certain salivating agents and a cooling agent selected from the group consisting of menthol, peppermint oil, N-substituted-p-menthane-3-carboxamides, acyclic tertiary and secondary carboxamides, 3-(1-menthoxy)propan-1,2-diol, monomenthyl glutarate and mixtures thereof. The amount of salivating agents according to US 2007/0036838 preferably is at least 100 ppm and most preferably lies in the range from about 0.02 wt. % (=200 ppm) to about 1 wt. %, based on the total weight of the medicament. In the examples given, the final concentration of trans-pellitorin in the ready-to-use products is 800 ppm.
EP 1 774 956 describes oral and dental hygiene and cleansing products that contain, based on their weight, a) at least 40% of at least one polyol selected from the group sorbitol, glycerin and/or 1,2-propylene glycol, and b) at least one salivation-promoting substance. Cis- and trans-pellitorin are mentioned as being preferred salivation-promoting substances. EP 1 774 956 mentions peppermint oil as a possible flavouring agent, menthol is not mentioned. The only cooling agent mentioned is N-ethyl-p-menthane-3-carboxamide (WS-3), EP 1 774 956 lists WS-3 as a warming/hot spicy substance.
WO 2007/068403 describes oral and dental hygiene and cleansing products that have a mineralizing and/or remineralizing effect if they contain, based on their weight, a) 0.005 to 10% of at least one calcium salt, and b) 0.005 to 10% of at least one salivation-promoting substance. Cis- and trans-pellitorin are mentioned as being preferred salivation-promoting substances. WO 2007/068403 mentions peppermint oil as a possible flavouring agent and menthol as a possible active ingredient in chewing gums. The only cooling agent mentioned is N-ethyl-p-menthane-3-carboxamide (WS-3), WO 2007/068403 lists WS-3 as a warming/hot spicy substance.
The present invention provides mixtures and products that effectively sooth irritated oral and/or nasal tissues and can reduce bitterness. The products described herein incorporate a mixture comprising (a) pellitorin and (b) selected cooling agents, said mixture and product modulating oral and/or nasal secretions, providing relief to a consumers oral and/or nasal tissues, in addition having reduced the bitterness.
The invention relates to a mixture comprising, consisting essentially or consisting of:
(a) pellitorin, and
(b) one or more physiological cooling agents selected from the group consisting of:
N-[[5-methyl-2-(1-methylethyl)cyclohexyl]-carbonyl]glycine ethyl ester, menthyl-3-hydroxy butyrate, menthyl-3-oxo butyrate, menthyl-3-oxo pentanoate, menthyl lactate, menthone glycerine acetal, menthol glycol carbonate, menthol propyleneglycol carbonate and menthol glycerin carbonate;
and optionally one or more compounds selected from the groups (c) and/or
(d) and/or (e)
(c) menthol and/or peppermint oil or mixtures thereof;
(d) one or more additional physiological cooling agents selected from the group consisting of: N-substituted-p-menthane-3-carboxamides, acyclic tertiary and secondary carboxamides, 3-(1-menthoxy)propan-1,2-diol, monomenthyl glutarate, monomenthyl succinate or its salts,
(e) one or more adjuvants selected from the group consisting of glycerin, ethylene glycol, 1,2-propylene glycol, diethyl malonate and/or dibutyl malonate.
Unless otherwise stated herein, all percentages are weight percentages. Unless otherwise stated herein, all measurements are taken at 20° C.
The present invention provides the use of a mixture comprising or consisting of (a) pellitorin and (b) selected cooling agents in the preparation of a product able to sooth irritated oral and/or nasal tissues by modulating oral and/or nasal secretion. As used herein, “oral” includes the buccal cavity, tongue and the throat, and “nasal” includes the nose, nasal cavity and the nasopharynx. As used herein, “soothing” includes relaxing, moisturizing, relieving, reducing pain and the like. Preferably, the product sooths irritated oral and nasal tissues by modulating oral and nasal secretions. Oral and nasal secretion includes salivation, moisturization and mucosal secretion, preferably in the nasal passage, nasal conchae, pharynx, nasopharynx, oral cavity, soft palate and the tongue.
In the context of the present invention pellitorin means 2,4-decadienoic acid-N-isobutylamide, wherein the two carbon-carbon-double bonds independently can have (E)- or (Z)-configuration. Thus, in the context of the present invention pellitorin means 2E,4E-decadienoic acid-N-isobutylamide (trans-pellitorin), 2E,4Z-decadienoic acid-N-isobutylamide (cis-pellitorin), 2Z,4Z-decadienoic acid-N-isobutylamide, 2Z,4E-decadienoic acid-N-isobutylamide, and mixtures thereof.
Preferred in the present invention are trans-pellitorin and/or cis-pellitorin and mixtures thereof, in particular mixtures wherein the weight ratio of trans-:cis-pellitorin is in the range of 40:1-1:1, more preferably in the range of 30:1-5:1, most preferably in the range of 25:1-10:1.
Methods of obtaining pellitorin suitable for use herein are described in WO 2004/000787 and US 2004/0241312.
The physiological cooling agents of part (b) are selected from the group consisting of:
N-[[5-methyl-2-(1-methylethyl)cyclohexyl]-carbonyl]glycine ethyl ester, menthyl-3-hydroxy butyrate, menthyl-3-oxo butyrate, menthyl-3-oxo pentanoate, menthyl lactate, menthone glycerine acetal, menthol glycol carbonate, menthol propyleneglycol carbonate and menthol glycerin carbonate and mixtures thereof.
N-[[5-methyl-2-(1-methylethyl)cyclohexyl]-carbonyl]glycine ethyl ester, is also known as WS-5, as for example described in U.S. Pat. No. 7,189,760, also commercially available from Millenium;
menthyl-3-hydroxy butyrate, preferably 1-menthyl-3-hydroxy butyrate, as described in FR 2 577 922;
menthyl-3-oxo butyrate and menthyl-3-oxo pentanoate are known from FR 2 577 922 and DE 38 16 360 respectively, the use of these compounds as cooling agents is described in U.S. Prov. 60/883,400 (Symrise GmbH & Co. KG) and patent applications claiming its priority;
menthyl lactate, preferably 1-menthyl lactate, more preferably I-menthyl I-lactate, as described in DE 26 08 226, for example commercially available as Frescolat® ML from Symrise; in a preferred embodiment of the present invention natural 1-menthyl-lactate is used (cf. Flavour Frag. J. 2006, 21, 725-730);
menthone glycerine acetal, preferably 1-menthone glycerine acetal as described in U.S. Pat. No. 5,266,592, for example commercially available as Frescolat® MGA from Symrise;
menthol glycol carbonate, menthol propyleneglycol carbonate and menthol glycerin carbonate as described in U.S. Pat. No. 5,703,123; preferred are l-menthol glycol carbonate (O-L-Menthyl-O′-(2-hydroxyethyl) carbonate), also known as Frescolat® MGC from Symrise, and l-menthol propylene glycol carbonate, also known as Frescolat® MPC from Symrise.
Part (c) consists of menthol and/or peppermint oil or mixtures thereof.
In the context of the invention, the menthol preferably is d-menthol, I-menthol or any desired mixture thereof, I-menthol, d-menthol and racemic menthol being preferred and I-menthol being particularly preferred.
Peppermint oils are understood as meaning specifically the essential (i.e. obtained by means of steam distillation) oils of certain Mentha species, in particular from Mentha arvensis (field mint, also called cornmint in US language) and from Mentha piperita (called peppermint in US language), which include Mentha piperita oils with names of regional origin from specific cultivation areas, such as Willamette, Yakima and Madras.
The optional physiological cooling agents of part (d) are selected from the group consisting of:
N-substituted-p-menthane-3-carboxamides, acyclic tertiary and secondary carboxamides, 3-(1-menthoxy)propan-1,2-diol (Coolant Agent 10 by Takasago), monomenthyl glutarate, monomenthyl succinate or its salts, and mixtures thereof.
The carboxamides found most useful are those described in U.S. Pat. No. 4,136,163, and U.S. Pat. No. 4,230,688. The carboxamides in U.S. Pat. No. 4,136,163 are N-substituted-p-menthane-3-carboxamides, such as N-ethyl-p-menthane-3-carboxamide, commercially available as WS-3 from Wilkinson Sword. The carboxamides of U.S. Pat. No. 4,230,688 are certain acyclic tertiary and secondary carboxamides, such as trimethyl isopropyl butanamide, commercially available as WS-23 from Wilkinson Sword. More preferred for use herein are monomenthyl glutarate, monomenthyl succinate, N-ethyl-p-menthane-3-carboxamide, trimethyl isopropyl butanamide and mixtures thereof.
Monomenthyl glutarate is commercially available as Ultracool 2 from IFF (Netherlands), monomenthyl succinate, or its alkali metal or alkaline earth metal salts, are described WO 97/07771 and commercially available from Mane Fils.
When present, these optional physiological cooling agents of part (d) can improve the soothing effect on irritated oral and/or nasal tissues of a mixture according to the present invention.
The optional adjuvants of part (e) are selected from the group consisting of:
glycerin, ethylene glycol, 1,2-propylene glycol, diethyl malonate, dibutyl malonate and mixtures thereof.
When present, these adjuvants can improve the soothing effect on irritated oral and/or nasal tissues and enhance the bitterness reducing effect of a mixture according to the present invention. In addition these adjuvants improve solubilization and stabilization of pellitorin of part (a) in said mixtures.
If a formulation (e.g. mixture, flavour composition, product or medicament) according to the present invention comprises pellitorin, propylene glycol, peppermint oil, L-Menthyl lactate and O-L-Menthyl-O′-(2-hydroxyethyl) carbonate, then the ratio by weight of pellitorin: L-Menthyl lactate: O-L-Menthyl-O′-(2-hydroxyethyl) carbonate (Frescolat® MGC from Symrise) is not 1:65:10.
Such mixtures have already been described in still unpublished PCT/EP2007/055157 (Symrise GmbH & Co. KG), U.S. Prov. 60/829,953 (Symrise GmbH & Co. KG) and U.S. Prov. 60/883,400 (Symrise GmbH & Co. KG).
Preferred according to the present invention are mixtures comprising or consisting of:
(a) trans-pellitorin and/or cis-pellitorin, and
(b) one or more physiological cooling agents selected from the group consisting of:
N-[[5-methyl-2-(1-methylethyl)cyclohexyl]-carbonyl]glycine ethyl ester, menthyl-3-hydroxy butyrate, menthyl-3-oxo pentanoate, menthyl lactate, menthone glycerine acetal, menthol glycol carbonate and menthol propyleneglycol carbonate; and
(c) menthol and/or peppermint oil or mixtures thereof; and
(e) one or more adjuvants selected from the group consisting of glycerin, ethylene glycol, 1,2-propylene glycol, diethyl malonate and/or dibutyl malonate;
and optionally
(d) one or more additional physiological cooling agents selected from the group consisting of N-substituted-p-menthane-3-carboxamides, acyclic tertiary and secondary carboxamides, 3-I-menthoxy propan-1,2-diol, monomenthyl glutarate, monomenthyl succinate.
More preferred according to the present invention are mixtures comprising or consisting of:
(a) trans-pellitorin, and
(b) one or more physiological cooling agents selected from the group consisting of:
N-[[5-methyl-2-(1-methylethyl)cyclohexyl]-carbonyl]glycine ethyl ester, menthyl-3-hydroxy butyrate, menthyl-3-oxo pentanoate, menthyl lactate, menthone glycerine acetal, menthol glycol carbonate and menthol propyleneglycol carbonate; and
(c) menthol; and
(e) one or more adjuvants selected from the group consisting of glycerin, 1,2-propylene glycol and/or diethyl malonate;
and optionally
(d) one or more additional physiological cooling agents selected from the group consisting of N-ethyl-p-menthane-3-carboxamide (WS-3), trimethyl isopropyl butanamide (WS-23), monomenthyl glutarate.
Most preferred according to the present invention are mixtures comprising or consisting of:
(a) trans-pellitorin and cis-pellitorin; and
(b) one or more physiological cooling agents selected from the group consisting of:
N-[[5-methyl-2-(1-methylethyl)cyclohexyl]-carbonyl]glycine ethyl ester, menthyl lactate, menthone glycerine acetal, menthol glycol carbonate and menthol propyleneglycol carbonate; and
(c) menthol and peppermint oil; and
(e) 1,2-propylene glycol and/or diethyl malonate;
and optionally
(d) N-ethyl-p-menthane-3-carboxamide and/or trimethyl isopropyl butanamide.
Preferably, a mixture according to the present invention comprises from 0.02% (200 ppm) to 2% pellitorin, more preferably from 0.05% (500 ppm) to 1.5%, most preferably from 0.10% (1000 ppm) to 1.25%, in each case based on the total weight of the mixture.
Preferably, the total amount of the cooling agents of part (b) in a mixture according to the present invention is in the range from 5% to 98%, preferably from 15% to 75%, in each case based on the total weight of the mixture.
The mixtures and products herein can additionally include a flavouring agent. As used herein, the term ‘flavouring agent’ means those flavour essences and equivalent synthetic ingredients which are added to the flavour composition for the principal purpose of providing flavour to the product. It excludes physiological warming and physiological cooling agents as well as the constituents of parts (a) to (e) of a mixture according to the present invention.
A flavour composition according to the present invention comprises
(i) a mixture according to the present invention as described herein above, and
(ii) one, two, three, four, five, six, seven, eight or more (additional) flavouring agents, said flavouring agents not being part of the mixture (i).
Flavouring agents well known in the art can be added to the flavour compositions of the invention. These flavouring agents can be chosen from synthetic flavouring liquid and/or oils derived from plants leaves, flowers, fruits and so forth, and combinations thereof. Representative flavouring liquids include: artificial, natural or synthetic fruit flavours such as eucalyptus, lemon, orange, banana, grape, lime, apricot and grapefruit oils and fruit essences including apple, strawberry, cherry, orange, pineapple and so forth; bean and nut derived flavours such as coffee, cocoa, cola, peanut, almond and so forth; and root derived flavours such as licorice or ginger.
Preferably, a flavouring composition according to the present invention comprises from 0.01% (100 ppm) to 1% pellitorin, more preferably from 0.025% (250 ppm) to 0.50% (5000 ppm), most preferably from 0.050% (500 ppm) to 0.25% (2500 ppm), in each case based on the total weight of the flavouring composition.
Preferably, a flavouring composition according to the present invention comprises from a total amount of 0.1% to 15% of the cooling agents of part (b) of the present invention, more preferably from 0.25% to 12%, most preferably from 0.5% to 8%, in each case based on the total weight of the mixture or flavouring composition.
A product according to the present invention preferably is a foodstuff, a confectionery product, an oral care product or a medicament.
Generally, a total amount of pellitorin in the range from 0.000055% to 0.0095% (corresponds to 0.55-95 ppm) can be incorporated into a product according to the present invention. Advantageously, a product according to the present invention comprises a total amount of pellitorin of less than 80 ppm, preferably in the range from 0.000055% to 0.0075% (corresponds to 0.55-75 ppm), more preferably in the range from 0.000075% to 0.005% (corresponds to 0.75-50 ppm), even more preferably in the range from 0.00009% to 0.0025% (corresponds to 0.9-25 ppm), most preferably in the range from 0.0001% to 0.00175% (corresponds to 1-17.5 ppm), in each case based on the total weight of the product.
The amount of flavouring employed in a product according to the present invention is normally a matter of preference subject to such factors as flavour type, base type and strength desired. In general, amounts of flavouring composition according to the present invention of up to 4% by weight are usable with amounts of from 0.1% to 1.50% of flavouring composition according to the present invention being preferred, in each case based on the total weight of the product.
The mixtures or flavouring compositions according to the present invention described herein above can be added to, for example, compositions for the preparation of carbonated fruit beverages, carbonated cola drinks, wine coolers, cordials, flavoured water, powders for drinks (e.g., powdered sports or “hydrating” drinks), hard candy, soft candy, taffy, chocolates, sugarless candies, chewing gum, bubble gum, condiments, spices and seasonings, dry cereal, oatmeal, granola bars, alcoholic beverages, energy beverages, juices, teas, coffees, salsa, gel beads, film strips for halitosis, gelatin candies, pectin candies, starch candies, lozenges, cough drops, throat lozenges, throat sprays, toothpastes and mouth rinses. Use levels of mixtures and of flavouring composition according to the present invention and relative amounts its constituents can be adjusted by persons of ordinary skill in the art depending of the flavour of the additives employed in the end use food or beverage, or the taste or flavour of the end product itself.
It was further found that mixtures and flavouring compositions according to the present are able to reduce the bitterness of confectionery, foodstuffs, oral care or medicaments, for example the when incorporated into chewing gum bases (which often taste bitter), confectionery or toothpaste bases having bitter notes, products containing sweeteners having bitter taste or after-taste, or the bitter taste of menthol, which is a known disadvantage of menthol, in particular at higher dosage levels.
It is also important to suppress the bitter taste of many pharmaceutical active ingredients, because the willingness of the patient, in particular of patients who are sensitive to bitterness, such as children, to take the preparation orally can be markedly increased as a result. Many pharmaceutical active ingredients, for example aspirin, salicin, paracetamol, or quinine, to name but only a few for the purposes of illustration, have a pronounced bitter taste and/or after-taste.
It was further found that mixtures, flavouring compositions and products according to the present invention show a prolonged cooling effect in the oral and/or nasal cavity. upon consumption. Thus, when used in the above indicated (preferred) amounts, a long-lasting cooling and/or freshening effect is observed, the cooling intensity of the cooling agents of part (b) generally not being augmented. A “long-lasting” effect means that the cooling and/or and freshening effect is perceived for a longer period of time in terms of taste. Surprisingly, not only a “long-lasting” cooling and/or freshening effect was observed, but additionally a prolonged soothing effect on irritated oral and/or nasal tissues. The “long-lasting” cooling and/or freshening effects were particularly observed in the presence of part (c) menthol and/or peppermint oil or mixtures thereof.
Thus, in a further aspect of the present invention, pellitorin is used for prolonging the cooling and/or freshening effect of the cooling agents of part (b) of the present invention, preferably in the presence of part (c) menthol and/or peppermint oil or mixtures thereof.
In addition, it was observed that pellitorin improved and rounded off the flavour profile of flavouring compositions and products according to the present invention. Improved and rounded off flavour profiles were particularly found in the presence of part (c) menthol and/or peppermint oil or mixtures thereof, while at the same time also reducing the bitterness of menthol and/or peppermint oil.
Products according to the present invention may comprise one or more food acids, preferably selected from the group consisting of acetic acid, adipic acid, aspartic acid, benzoic acid, sorbic acid, caffeotannic acid, citric acid, iso-citric acid, fumaric acid, galacturonic acid, glucuronic acid, glyceric acid, glycolic acid, ketoglutaric acid, [alpha]-ketoglutaric acid, lactic acid, lactoisocitric acid, malic acid, oxalacetic acid, oxalic acid, pyruvic acid, quinic acid, shikimic acid, succinic acid, tannic acid, and tartaric acid. In a preferred embodiment, the food acids is selected from citric acid, lactic acid, malic acid, succinic acid, fumaric acid, tartaric acid, ascorbic acid or adipic acid.
The flavouring compositions and products of the present invention may further comprise a physiological warming agent.
Preferred physiological warming agents are those selected from the group consisting of vanillyl alcohol n-butyl ether, vanillyl alcohol n-propyl ether, vanillyl alcohol isopropyl ether, vanillyl alcohol isobutyl ether, vanillyl alcohol n-amino ether, vanillyl alcohol isoamyl ether, vanillyl alcohol n-hexyl ether, vanillyl alcohol methyl ether, vanillyl alcohol ethyl ether, gingerol, shogaol, paradol, zingerone, capsaicin, dihydrocapsaicin, nordihydrocapsaicin, homocapsaicin, homodihydrocapsaicin, iso-propyl alcohol, iso-amylalcohol, benzyl alcohol, eugenol, cinnamon oil, cinnamic aldehyde, and mixtures thereof.
The products comprising a mixture or a flavour composition according to the present invention are regularly products which are intended to be introduced into the human oral cavity, to remain there for a certain period of time and then either to be consumed (e.g. foodstuffs) or to be removed from the oral cavity again (e.g. chewing gums or toothpaste). In this context, these products include all substances or products which are intended to be taken in by humans in the processed, partly processed or non-processed state. These also include substances which are added to foodstuffs during their production, processing or preparation and are envisaged for introduction into the human oral cavity.
Foodstuffs according to the present invention are for example bakery products (for example bread, dry biscuits, cakes, other pastry products), confectionery (for example chocolates, chocolate bar products, other bar products, fruit gums, hard and soft caramels, chewing gum), alcoholic or non-alcoholic beverages (for example coffee, tea, wine, beverages containing wine, beer, beverages containing beer, liqueurs, spirits, brandies, (fruit-containing) carbonated beverages, isotonic beverages, soft drinks, nectars, fruit and vegetable juices, fruit or vegetable juice preparations), instant beverages (for example instant cocoa beverages, instant tea beverages, instant coffee beverages), meat products (for example ham, fresh or cured sausage preparations, spiced or marinated fresh or cured meat products), eggs or egg products (dried egg, egg white, egg yolk), cereal products (for example breakfast cereals, muesli bars, precooked ready rice products), dairy products (for example milk beverages, milk ice cream, yogurt, kefir, curd cheese, soft cheese, hard cheese, dried milk powder, whey, butter, buttermilk), fruit preparations (for example jams, fruit ice cream, fruit sauces, fruit fillings), vegetable preparations (for example ketchup, sauces, dried vegetables, deep-frozen vegetables, precooked vegetables, preserved vegetables), snack articles (for example baked or fried potato chips or potato dough products, maize- or peanut-based extrudates), fat- or oil-based products or emulsions thereof (for example mayonnaise, remoulade, dressings), other ready-to-serve meals and soups (for example dried soups, instant soups, precooked soups), spices, seasoning mixtures and in particular powdered seasonings, which are for example used in snack food applications. The products for the purposes of the invention may also be nutritional supplements in the form of capsules, tablets (uncoated and coated tablets, for example coatings resistant to gastric juices), sugar-coated tablets, granules, pellets, mixtures of solids, dispersions in liquid phases, as emulsions, as powders, as solutions, as pastes or as other swallowable or chewable preparations.
An oral care product (also called oral hygiene product) in the context of the invention is understood as meaning one of the formulations familiar to the person skilled in the art for cleansing and care of the oral cavity and the pharyngeal cavity and for refreshing the breath. This expressly includes care of the teeth and gums. Presentation forms of the usual oral hygiene formulations are creams, gels, pastes, foams, emulsions, suspensions, aerosols and sprays, and also capsules, granules, pastilles, tablets, candies or chewing gums, without this list being intended to be understood as limiting for the purpose of this invention.
Preferred oral care products are in particular dental care products such as toothpastes, dental creams, dental gels, dental powders, tooth-cleaning liquids, tooth-cleaning foams, mouthwashes, dental cream and mouthwash as a 2-in-1 product, sugar-free candies for sucking, oral sprays, dental floss or dental care chewing gums.
Dental care products (as an example of the group of oral care products) which contain a mixture according to the invention generally comprise an abrasive system (abrasive or polishing agent), such as for example silicas, calcium carbonates, calcium phosphates, e.g. calcium-glycerophosphates, the Ca-salt of glycerol-1-phosphoric acid, glycerol-2-phosphoric acid or glycerol-3-phosphoric acid, or mixtures thereof, aluminum oxides and/or hydroxyapatites, surface-active substances such as for example sodium lauryl sulfate, sodium lauryl sarcosinate and/or cocamidopropyl betaine, humectants such as for example glycerol and/or sorbitol, thickeners, such as for example carboxymethylcellulose, polyethylene glycols, carrageenan and/or Laponite®, sweeteners, such as for example saccharin, sodium cyclamate, sucralose, acesulfame-K or sugar alcohol flavour-correcting agents for unpleasant flavour impressions such as for example hydroxyflavanones according to US 2002/0188019, flavour-correcting agents for further, generally not unpleasant flavour impressions, flavour-modulating substances (for example inositol phosphate, nucleotides such as guanosine monophosphate, adenosine monophosphate or other substances such as sodium glutamate or 2-phenoxypropionic acid), cooling active ingredients, stabilizers and active ingredients, such as for example sodium fluoride, sodium monofluorophosphate, tin difluoride, quaternary ammonium fluorides, zinc citrate, zinc sulfate, tin pyrophosphate, tin dichloride, blends of different pyrophosphates, triclosan (2,4,4′-trichlor-2′-hydroxydiphenyl ether), cetylpyridinium chloride, aluminum lactate, potassium citrate, potassium nitrate, potassium chloride, potassium oxalate, strontium chloride, hydrogen peroxide, aromas and/or sodium bicarbonate or flavour-correcting agents.
Chewing gums (as a preferred example of the group of oral care products or confectionery) which contain a mixture according to the invention generally comprise a chewing gum base, i.e. a chewable mass which becomes plastic on chewing, sugars of various kinds, sugar substitutes, other sweet-tasting substances, sugar alcohols, flavour-correcting agents for unpleasant flavour impressions, other flavour modulators for further, generally not unpleasant flavour impressions, flavour-modulating substances (for example inositol phosphate, nucleotides such as guanosine monophosphate, adenosine monophosphate or other substances such as sodium glutamate or 2-phenoxypropionic acid), humectants, thickeners, emulsifiers, aromas and stabilizers or flavour-correcting agents.
Preferably the products in accordance with the present invention include one or more sweet-tasting substances (including natural sources of these substances), such as for example sweet-tasting carbohydrates or sugars (e.g. sucrose (synonymous with saccharose), trehalose, lactose, maltose, melizitose, raffinose, palatinose, lactulose, D-fructose, D-glucose, D-galactose, L-rhamnose, D-sorbose, D-mannose, D-tagatose, D-arabinose, L-arabinose, D-ribose, D-glyceraldehyde, maltodextrin) or vegetable preparations containing predominantly these carbohydrates (e.g. from sugar beet (Beta vulgaris ssp., sugar fractions, sugar syrup, molasses), from sugar cane (Saccharum officinarum ssp., e.g. molasses, sugar syrups), from sugar maple (Acer ssp.), from agave (agave thick juice), synthetic/enzymatic hydrolysates of starch or sucrose (e.g. invert sugar syrup, highly enriched fructose syrups made from corn starch), fruit concentrates (e.g. from apples or pears, apple syrup, pear syrup), sugar alcohols (e.g. erythritol, threitol, arabitol, ribitol, xylitol, sorbitol, mannitol, dulcitol, lactitol), proteins (e.g. miraculin, monellin, thaumatin, curculin, brazzein), sweeteners (magap, sodiumcyclamate, acesulfame K, neohesperidin dihydrochalcone, saccharin sodium salt, aspartame®, superaspartame, neotame, alitame, sucralose, stevioside, rebaudioside, lugduname, carrelame, sucrononate, sucrooctate, monatin, phyllodulcin), certain sweet-tasting amino acids (glycine, D-leucine, D-threonine, D-asparagine, D-phenylalanine, D-tryptophan, L-proline), other sweet-tasting low-molecular substances (e.g. hernandulcin, dihydrochalcone glycosides, glycyrrhizin, glycyrrhetinic acid ammonium salt or other glycyrrhetinic acid derivatives), liquorice extracts (Glycyrrhizza glabra ssp.), Lippia dulcis extracts, Momordica ssp. extracts or individual substances (in particular Momordica grosvenori [Luo Han Guo] and the mogrosides obtained therefrom), Hydrangea dulcis or Stevia ssp. (e.g. Stevia rebaudiana) extracts or individual substances.
A suitable confectionery sugar base, e.g. for a hard candy, generally comprises from about 30% to about 85% glucose syrup and from about 15% to about 70% sucrose. Alternatively, a sugar-free base can be used for the shell.
Suitable sugar-free bases, e.g. for confectionery and oral care products, generally include bulk sweeteners such as isomalt, maltitol, sorbitol and xylitol. Isomalt and maltitol are preferred as bulk sugar-free bases. Xylitol is preferred as an ancillary base, preferably being present in sugar-free candies at a level of from about 0.1% to about 5%.
Products of the present invention may comprise sweeteners, preferably selected from the group saccharin, sodium cyclamate, sucralose, acesulfame-K and aspartame.
Combinations of a mixture according to the present invention and one or more sugar alcohols selected from the group consisting of xylitol, sorbitol, mannitol and erythritol showed enhanced soothing and cooling effects.
Suitable confectionery forms include hard boiled sweets, soft boiled sweets, chewing gums, gummy-based sweets, centre-fill confectionery, or lollies. The confectionery compositions of the present invention preferably take the form of a hard boiled sweet.
Medicaments according to the invention which are preferred for the purposes of the invention are oral preparations, which for example have the form of capsules, tablets (uncoated and coated tablets, for example coatings resistant to gastric juices), sugar-coated tablets, granules, pellets, mixtures of solids, dispersions in liquid phases, as emulsions, as powders, as solutions, as pastes or as other swallowable or chewable preparations and are used as prescription-only, drugstore-only or other medicaments or as nutritional supplements.
Preferably a medicament of the present invention has the form of confectionery, chewing gum, throat and cough lozenge, throat disc or cough syrup. Preferably the medicament is in the form of a confectionery. In a preferred embodiment the medicaments of the present invention are in the form of a hard boiled candy or gum based confectionery. Hard boiled candies are sugar- or sugar substitute-based compositions wherein the base is formed into a candy mass with cooking and subsequently formed into a drop and allowed to cool. The candy mass once cooled generally forms a glassy matrix that contains the mixture or flavouring composition according to the present invention therein. Once formed, the hard boiled candies preferably have a water level of about 0.1% to about 4% by weight. Gum based confectionery are soft to semi-solid compositions which are sugar or sugar-substitute based, wherein a suitable gelling agent is cooked with the sugar or sugar-substitute and water to achieve the right consistency, and either deposited into moulds or extruded into a continuous rope & cut.
Other preferred forms of the medicament of the present invention are cough lozenges and cough syrups. Cough lozenges are sugar-based solid or semi-solid compositions, preferably in the form of hard boiled candies and/or gummies. A suitable cough lozenge generally comprises from about 30% to about 50% of glucose syrup and from about 15% to about 75% of sucrose. Cough lozenges may further comprise honey, honey derivatives and/or honey flavours or lenitive herbs, preferably in concentration from about 0.05% to 10%, preferably from 0.1% to 5% by weight.
Cough syrups are sugar-based liquid composition further comprising additional active ingredients, such guaifenesin. Cough syrups generally comprise from about 25% to about 65% of sucrose. Additionally, from about 30% to about 45% of glucose syrup may be further comprised in the formulation of cough syrups.
A medicaments of the present invention may further comprise other active ingredients such as local anaesthetics, antitussives, decongestants and the like. The medicaments may also comprise pH adjusting agents and buffers in order to control the pH and hence the stability of the medicament. Other optional ingredients include organic acids including citric, ascorbic, malic, tartaric acids, or mixtures thereof. Where the medicament is the form of a water-based syrup, the medicament may further comprise thickening agents that impart an increased viscosity to the liquid formulation.
Without wishing to be bound by theory it is believed that the mixtures and products of the present invention provide improved soothing of oral and/or nasal tissues by a synergistic action of modulating oral and/or nasal secretions and improved cooling and soothing sensation associated with the cooling agent. The two ingredients act together to provide an improved composition that soothes and relieves irritated oral and/or nasal tissues.
The following examples are given to illustrate the mixtures and uses according to the invention. However, the invention is not limited thereto. Unless indicated otherwise the amounts given are by weight.
arvensis)
A strongly cooling, virtually flavourless and odorless aroma blend which is liquid at room temperature (20° C.) is obtained by blending the constituents.
A strongly cooling aroma blend with a strong odor of peppermint is obtained by blending the constituents.
A strongly cooling aroma blend which stimulates salivation and causes a tingling effect is obtained by blending the constituents.
Chewing gum base K1 comprised 2.0% butyl rubber (isobutene/isoprene copolymer, MW 400,000), 6.0% polyisobutene (MW=43,800), 43.5% polyvinyl acetate (MW 12,000), 31.5% polyvinyl acetate (MW=47,000), 6.75% triacetin and 10.25% calcium carbonate. Chewing gum base K1 and the chewing gums can be prepared analogously to U.S. Pat. No. 5,601,858.
The bubble gum can be prepared analogously to U.S. Pat. No. 5,093,136.
The chewing gums of recipe (I) were shaped as compact balls, and those of recipe (II) were shaped as hollow balls.
Chewing gum base K2 comprised 28.5% terpene resin, 33.9% polyvinyl acetate (MW=14,000), 16.25% hydrogenated plant oil, 5.5% mono- and diglycerides, 0.5% polyisobutene (MW 75,000), 2.0% butyl rubber (isobutene/isoprene copolymer), 4.6% amorphous silicon dioxide (water content approx. 2.5%), 0.05% antioxidant tert-butylhydroxytoluene (BHT), 0.2% lecithin, and 8.5% calcium carbonate. Chewing gum base K2 and the chewing gums can be prepared analogously to U.S. Pat. No. 6,986,907.
The chewing gums of recipe (I) and (II) were shaped as strips, and those of recipe (III) were shaped as pellets.
The gelatine capsule, which is suitable for direct consumption, was prepared in accordance with WO 2004/050069 and had a diameter of 5 mm, and the weight ratio of core material to shell material was 90:10. The capsules opened in the mouth within less than 10 seconds and dissolved completely within less than 50 seconds.
Preparation Instructions (see also WO 03/092412):
All the constituents were mixed and the mixture was conveyed in a twin-screw extruder by one-point metering. The extrusion temperatures were between 100 and 120° C. and the specific energy input was 0.2 kWh/kg. The strands emerging from the extruder die plate, which was provided with 1 mm bores, were cut to particles of approx. 1 mm diameter by rotating blades immediately after exit from the dies.
A solution consisting of 44 wt. % water, 11 wt. % Mixture X1 (according to the invention from Example 4), 13 wt. % gum arabic and 32 wt. % hydrolysed starch (maltodextrin DE 15-19) and some green dyestuff is granulated in a granulating apparatus of the type described in EP 163 836 (with the following features: diameter of in-flow tray 225 mm, spray nozzle: two-component nozzle; sifting discharge: zigzag sifter; filter: internal bag filter). The solution is sprayed into the fluidized bed granulator at a temperature of 32° C. To fluidize the contents of the bed, an amount of 140 kg/h of nitrogen is blown in. The entry temperature of the fluidizing gas is 140° C. The temperature of the waste gas is 76° C. Nitrogen is likewise fed in as the sifting gas in an amount of 15 kg/h at a temperature of 50° C. The contents of the fluidized bed is approx. 500 g. The granulation output is approx. 2.5 kg per hour. Free-flowing granules having an average particle diameter of 360 micrometres are obtained. The granules are circular and have a smooth surface. On the basis of the constant pressure loss of the filter and the content of the bed, which likewise remains constant, stationary conditions are to be assumed in respect of the granulation process.
Q1: Chewing gum base composition constituents
Q2: Coating constituents (covering) (the weight contents stated relate to the total weight of the coating (Q2) applied to the chewing gum pads (Q1); the total weight of Q2 was about 35%, based on the weight of Q1)
All the constituents of the chewing gum base composition (Q1) were mixed, stamped into chewing gum strands and then shaped into individual chewing gum pads. The chewing gum pads were then wetted (gummed) with a 40 wt. % strength gum arabic solution in a rotating dragée-coating drum. The gummed chewing gum pads were then coated in a rotating dragée-coating drum with the pulverulent mixture A, which substantially comprised spray-dried I-menthol and at least one sugar substitute (usually chosen from isomalt, sorbitol, xylitol, maltitol and/or mannitol, pulverulent gum arabic can optionally additionally be used). After adequate drying with cold air, the chewing gum pads coated in this way were dried overnight. For further application of the coating to the dried, coated chewing gum pads using coating solution B, 15 layers were first applied by means of dragée-coating, and in the 16th layer a mixture of constituent C and mixture B was applied. Thereafter, further layers were applied using mixture B, until the total weight of the coating (Q2) was about 35 wt. % of the weight of the original chewing gum pads (Q1). In order to impart gloss to the chewing gum dragées, a final treatment was carried out with a polishing agent, which comprised a mixture of equal weight contents of carnauba wax and beeswax.
A spray-dried aroma according to the invention colored green-yellow (comprising maltodextrin (DE: 18-20), dextrose, gum arabic, Mixture X2 (of Example 5), dyestuff and the antioxidant ascorbyl palmitate) with the following particle size distribution was prepared via a pressure nozzle:
D (v 0.1): 26.8 micrometres,
D (v 0.5): 68.02 micrometres,
D (v 0.9): 126.4 micrometres
45 g of this instant drink powder were dissolved in 1,000 ml, while stirring. The drink obtained had a refreshing, cooling flavour of lemon and menthol-peppermint.
The sugar, corn syrup and maltose were dissolved in water and the solution was boiled and placed under a vacuum. The remaining ingredients were then sucked into the boiled sugar mass and the mixture was homogenized at the boiling temperature. After cooling, hard caramels were stamped out of the resulting mass. The hard caramels showed a residual water content of about 2.5 wt. %.
Bonbons having a liquid-viscous core were prepared in accordance with the processes described in U.S. Pat. No. 6,432,441 (Example 1 there) and in U.S. Pat. No. 5,458,894 and U.S. Pat. No. 5,002,791. The two parts A and B were processed separately to bases for the shell (Part A) and core (Part B). The filled throat candies obtained by means of co-extrusion acted against coughing, sore throat and hoarseness when consumed by affected persons.
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/EP2007/058545 | 8/16/2007 | WO | 00 | 5/5/2010 |
